|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, September 18, 2014 ) Dallas, TX -- A peptic ulcer is an open lesion that develops on the mucosal lining of the stomach and small intestine because of the caustic effect of the gastric acids and enzymes in these organs. The symptoms of peptic ulcers are pain in the abdomen, nausea, vomiting, and bloated stomach. The major symptoms include bleeding from the ulcer, which can be life-threatening. It is detected by bloody and sticky stools, often black in color. Peptic ulcers are caused mainly by a Helicobacter pylori infection followed by the overuse of OTC NSAIDs such as Naproxen, Aspirin and Ibuprofen. Peptic ulcers can be of two types based on the site of the ulcer: gastric ulcer and duodenal ulcer.
Analysts forecast the Global Peptic Ulcer Drugs market to grow at a CAGR of 2.9 percent over the period 2013-2018.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Peptic Ulcer Drugs market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the treatment of peptic ulcers that are available in the market.
Global Peptic Ulcer Drugs Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Peptic Ulcer Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=205276 .
Key Regions
Americas
EMEA
APAC
Key Vendors
AstraZeneca plc
Eisai Co. Ltd.
Daewoong Pharmaceutical Co. Ltd.
Takeda Pharmaceutical Co. Ltd.
Other Prominent Vendors
Daiichi Sankyo
Dr. Reddy’s Laboratories
Eumedica
Ferring Pharmaceuticals
Horizon Pharma
Johnson and Johnson
Merck Sharp and Dohme
Otsuka Holdings
Pfizer
PharmaKing
Pozen
Rottapharm Madaus
Taiho Pharmaceutical
Zeria Pharmaceutical
Zuventus Healthcare
Market Driver
Increased Incidence of H. pylori Infections.
For a full, detailed list, view our report.
Market Challenge
Adverse Effect of PPIs.
For a full, detailed list, view our report.
Market Trend
Use of Combination Drugs.
For a full, detailed list, view our report.
Key Questions Answered in this Report
What will the market size be in 2018 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Single User License is US $2500 for Discount Inquire@ http://www.rnrmarketresearch.com/contacts/discount?rname=205276.
About us:Rnrmarketresearch.com is your single source for all market research needs. Our database includes 100,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
RnR Market Research
Ritesh Tiwari
+ 1 888 391 5441
sales@rnrmarketresearch.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
